IMAX Corporation
NYSE:IMAXEntertainment
+$0.46 today
- Market cap
- $2.58B
- Beta
- 0.37
- P/E (TTM)
- 65.9
- EPS (TTM)
- $0.68
Volume 0.95M
Average 1.13M
IMAX Interest Expense
Cost of servicing the company's debt during the period.
IMAX CorporationNYSE: IMAX
Interest Expense · Q3 FY2026 · quarter ended Sep 2026
Interest expense dips below year-ago levels
Q3 FY2026 interest expense of $1.77M fell 3.2% year over year, behind the +3.6% change in trailing-twelve-month interest expense. Sequentially, it fell 9.5% from the prior quarter. Over 3 fiscal years it compounded at +7.8% a year.
Context
- Interest expense amounted to 1.8% of revenue in FY2025, down 0.5 pp from a year earlier.
- Interest expense increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -3.2% toward the trailing-twelve-month pace of +3.6%.
Sources:Income StatementText generated from reported figures; not investment advice.
Interest Expense history
USD · from the income statement
- Latest · FY2025
- 7.36M USD
- Year-over-year change
- -8.9%
- 4-year CAGR
- +0.9%
| Period | Period end | Interest Expense | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 7.36M | -8.9% |
| FY2024 | 2024-12-31 | 8.08M | +18.5% |
| FY2023 | 2023-12-31 | 6.82M | +16.1% |
| FY2022 | 2022-12-31 | 5.88M | -17.1% |
| FY2021 | 2021-12-31 | 7.09M | — |
Interest Expense vs competitors
How IMAX compares with its peers on the latest reported figures
- Peers report in different currencies, so interest expense is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +3.6% is the 2nd highest of 9, against a peer median of -8.5%.
- Interest expense amounts to 1.5% of revenue for IMAX, versus a peer median of 5.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $539M USD | +9.5% | +11.9% | 10.3% | |
| LTM Jun 2026 | $214.8M USD | -9.1% | +16.9% | 7.5% | |
| LTM Mar 2026 | CN¥125.32M CNY | -84.6% | -43.9% | 3.4% | |
| LTM Mar 2026 | $108.12M USD | -7.9% | +5.0% | 3.0% | |
| LTM Sep 2026 | $92.58M USD | -7.1% | +10.8% | 10.3% | |
| LTM Jul 2026 | $46.73M USD | -8.0% | +5.1% | 2.8% | |
| LTM Jun 2026 | $39.96M USD | -20.9% | -8.3% | 3.8% | |
| LTM Sep 2026 | $7.43M USD | +3.6% | +7.8% | 1.5% | |
| LTM Jun 2026 | $5.85M USD | -45.2% | — | 147.1% | |
| Peer median (excluding IMAX) | — | -8.5% | +5.1% | 5.6% | |
Competitors are the stored peer set for IMAX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 254.88M | 300.81M | 374.84M | 352.21M | 410.21M |
| Cost of Revenue | 120.48M | 144.45M | 160.5M | 162.01M | 172.64M |
| Gross Profit | 134.41M | 156.36M | 214.34M | 190.2M | 237.57M |
| Gross Margin | 52.7% | 52.0% | 57.2% | 54.0% | 57.9% |
| Research & Development | 6.94M | 5.3M | 10.11M | 5.1M | 4.12M |
| Selling, General & Admin | 117.79M | 138.04M | 144.41M | 132.7M | 137.85M |
| Operating Expenses | 123.42M | 161.19M | 163.94M | 146.34M | 141.97M |
| Depreciation & Amortization | 56.08M | 56.66M | 60.02M | 65.5M | 62.45M |
| EBITDA | 74.16M | 52.77M | 112.96M | 111.29M | 133.1M |
| EBITDA Margin | 29.1% | 17.5% | 30.1% | 31.6% | 32.4% |
| Operating Income | 10.98M | (4.83M) | 50.4M | 43.86M | 95.6M |
| Operating Margin | 4.3% | -1.6% | 13.4% | 12.5% | 23.3% |
| Interest Income | 2.22M | 1.43M | 2.49M | 2.18M | 2.8M |
| Interest Expense | 7.09M | 5.88M | 6.82M | 8.08M | 7.36M |
| Other Income / Expenses | 3K | (4.94M) | (4.28M) | (6.16M) | (32.31M) |
| Income Before Tax | 10.99M | (9.77M) | 46.12M | 37.7M | 63.29M |
| Pre-Tax Margin | 4.3% | -3.2% | 12.3% | 10.7% | 15.4% |
| Income Tax Expense | 20.56M | 10.11M | 13.05M | 5M | 17.77M |
| Net Income | (22.33M) | (22.8M) | 25.34M | 26.06M | 34.88M |
| Net Margin | -8.8% | -7.6% | 6.8% | 7.4% | 8.5% |
| EPS (Basic) | (0.38) | (0.40) | 0.47 | 0.49 | 0.65 |
| EPS (Diluted) | (0.38) | (0.40) | 0.46 | 0.48 | 0.63 |
| Weighted Avg Shares | 59.13M | 56.67M | 54.31M | 52.65M | 53.64M |
| Weighted Avg Shares (Diluted) | 59.13M | 56.67M | 55.15M | 53.86M | 55.54M |
IMAX Corporation
NYSE:IMAX
Intrinsic Alpha fair value
Locked
Current Price
$46.79
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.